Blas Frangione
- Physiology top 0.02%
- Molecular Biology top 0.1%
- Neurology top 0.05%
- Neurology top 0.2%
- Cellular and Molecular Neuroscience top 0.5%
- Co-authors
- Jorge GhisoThomas WısnıewskıFrances PrelliEdward C. FranklinEduardo M. CastañoBerislav V. ZlokovićClaudio SotoAgueda Rostagno
- Topics
- Alzheimer's disease research and treatments (176 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (98 papers)Monoclonal and Polyclonal Antibodies Research (74 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Blas Frangione
355 papers receiving 26.7k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Physiology 16.0k
- Molecular Biology 15.0k
- Neurology 4.3k
- Neurology 3.0k
- Cellular and Molecular Neuroscience 2.8k
Countries citing papers authored by Blas Frangione
This map shows the geographic impact of Blas Frangione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blas Frangione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blas Frangione more than expected).
Fields of papers citing papers by Blas Frangione
This network shows the impact of papers produced by Blas Frangione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blas Frangione. The network helps show where Blas Frangione may publish in the future.
Co-authorship network of co-authors of Blas Frangione
This figure shows the co-authorship network connecting the top 25 collaborators of Blas Frangione. A scholar is included among the top collaborators of Blas Frangione based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blas Frangione. Blas Frangione is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 150 | |
| 3 | 210 | |
| 4 | 214 | |
| 5 | 34 | |
| 6 | 200 | |
| 7 | β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapybreakdown → | 742 |
| 8 | 335 | |
| 9 | 53 | |
| 10 | 120 | |
| 11 | 5 | |
| 12 | 135 | |
| 13 | 3 | |
| 14 | 48 | |
| 15 | 15 | |
| 16 | 127 | |
| 17 | 113 | |
| 18 | 50 | |
| 19 | 35 | |
| 20 | 150 |
About Blas Frangione
Blas Frangione is a scholar working on Physiology, Neurology and Molecular Biology, having authored 355 papers that have together received 27.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (176 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (98 papers) and Monoclonal and Polyclonal Antibodies Research (74 papers). The work is most often cited by research in Physiology (16.0k citations), Neurology (4.3k citations) and Biological Psychiatry (649 citations). Blas Frangione has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Jorge Ghiso, Thomas Wısnıewskı, Frances Prelli, Edward C. Franklin, Eduardo M. Castaño, Berislav V. Zloković, Claudio Soto, Agueda Rostagno, Fabrizio Tagliavini and E. C. Franklin. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.